文献速递肿瘤 PET/CT核素与放射性配体治疗

从全身[68Ga]Ga-PSMA-11 PET/CT图像转移性前列腺病灶分割中全自动提取预后生物标志物

Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT images.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-08-17

本研究基于337例生化复发前列腺癌患者的全身[68Ga]Ga-PSMA-11 PET/CT图像,开发并评估基于深度学习的自动分割框架以提取患者级预后生物标志物。患者级分类准确率、灵敏度和PPV均>90%,PPV最高达97.2%;自动分割计算的全身体病灶总量(TLVauto)和总病灶摄取量(TLUauto)与患者总生存期显著相关(均p<0.005)。

要点

  • 患者级分类准确率、灵敏度和PPV均>90%,PPV最高为97.2%。
  • 病灶级检测PPV为88.2%、灵敏度为73.0%。
  • TLVauto和TLUauto与总生存期显著相关(均p<0.005)。

核心结论

  • 基于深度学习的全身[68Ga]Ga-PSMA-11 PET/CT全自动评估展现出显著前景,可实现准确的扫描分类、观察者间变异范围内的体素级分割,以及可能与患者总生存期相关的有潜在临床价值的预后生物标志物。

研究设计与样本

  • 研究纳入337例生化复发前列腺癌患者的[68Ga]Ga-PSMA-11 PET/CT图像,采用基于自配置nnU-Net框架的全3D卷积神经网络(CNN),在其中一部分扫描上训练,并保留独立测试集用于模型评估。

主要发现

  • 患者级分类的准确率、灵敏度和PPV均>90%,其中PPV最佳为97.2%。
  • 病灶级检测的PPV为88.2%,灵敏度为73.0%。
  • 体素级DSC中位数为50.7% vs 第二观察者32%(p=0.012);体素级PPV中位数为64.9% vs 第二观察者25.7%(p<0.005),均处于实测观察者间变异范围内。
  • Kaplan-Meier分析显示TLVauto和TLUauto与患者总生存期显著相关(均p<0.005)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to develop and assess an automated segmentation framework based on deep learning for metastatic prostate cancer (mPCa) lesions in whole-body [68Ga]Ga-PSMA-11 PET/CT images for the purpose of extracting patient-level prognostic biomarkers. METHODS: Three hundred thirty-seven [68Ga]Ga-PSMA-11 PET/CT images were retrieved from a cohort of biochemically recurrent PCa patients. A fully 3D convolutional neural network (CNN) is proposed which is based on the self-configuring nnU-Net framework, and was trained on a subset of these scans, with an independent test set reserved for model evaluation. Voxel-level segmentation results were assessed using the dice similarity coefficient (DSC), positive predictive value (PPV), and sensitivity. Sensitivity and PPV were calculated to assess lesion level detection; patient-level classification results were assessed by the accuracy, PPV, and sensitivity. Whole-body biomarkers total lesional volume (TLVauto) and total lesional uptake (TLUauto) were calculated from the automated segmentations, and Kaplan-Meier analysis was used to assess biomarker relationship with patient overall survival. RESULTS: At the patient level, the accuracy, sensitivity, and PPV were all > 90%, with the best metric being the PPV (97.2%). PPV and sensitivity at the lesion level were 88.2% and 73.0%, respectively. DSC and PPV measured at the voxel level performed within measured inter-observer variability (DSC, median = 50.7% vs. second observer = 32%, p = 0.012; PPV, median = 64.9% vs. second observer = 25.7%, p < 0.005). Kaplan-Meier analysis of TLVauto and TLUauto showed they were significantly associated with patient overall survival (both p < 0.005). CONCLUSION: The fully automated assessment of whole-body [68Ga]Ga-PSMA-11 PET/CT images using deep learning shows significant promise, yielding accurate scan classification, voxel-level segmentations within inter-observer variability, and potentially clinically useful prognostic biomarkers associated with patient overall survival. TRIAL REGISTRATION: This study was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12615000608561) on 11 June 2015.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kendrick J, Francis RJ, Hassan GM, et al. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT images. Eur J Nucl Med Mol Imaging. 2022. PMID: 35976392. doi:10.1007/s00259-022-05927-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。